HomeMy WebLinkAboutCouncil Information Memorandum 04-18-2019CITY OF PLYMOUTH
COUNCIL INFO MEMO
April 18, 2019
EVENTS / MEETINGS
Housing & Redevelopment Authority Agenda for April 25 ...................................... Page 2
Official City Meeting Calendars .................................................................... Page 3
Tentative List of Agenda Items ..................................................................... Page 6
CORRESPONDENCE
Home Alone Workshops for Children Slated for May ............................................ Page 9
Site Plan Amendment and Variance for 13600 Industrial Park Boulevard (2019016) ..... Page 10
REPORTS & OTHER ARTICLES OF INTEREST
Pelican BioThermal Announces Asia Award
for Excellence, Pharmaceutical Online News ............................................... Page 11
Sterilization Plant Closure in Illinois is a Challenge for
Minnesota Medical Device Makers, StarTribune ............................................. Page 13
Startup Raises $6M to Turn Silkworm Cocoons
into Eyedrops, Minneapolis/St. Paul Business Journal ..................................... Page 15
MEETING AGENDA
PLYMOUTH HOUSING AND REDEVELOPMENT AUTHORITY
THURSDAY, APRIL 25, 2019 - 7:00 p.m.
WHERE: Parkers Lake Room
City of Plymouth
3400 Plymouth Boulevard
Plymouth, MN 55447
CONSENT AGENDA
All items listed on the Consent Agenda are considered to be routine by the
Housing and Redevelopment Authority and will be enacted by one motion.
There will be no separate discussion of these items unless a Commissioner,
citizen or petitioner so requests, in which event the item will be removed
from the consent agenda and considered in normal sequence on the agenda.
1.CALL TO ORDER - 7:00 P.M.
2.PUBLIC FORUM
3.CONSENT AGENDA
A.Approve HRA Meeting Minutes for February 28, 2019.
B.Plymouth Towne Square. Accept Monthly Housing Reports.
C.Vicksburg Crossing. Accept Monthly Housing/Marketing Reports.
4.NEW BUSINESS
A.HRA Strategic Plan.
B.Sand Companies. Request for financial assistance to cover a portion of
city imposed fees.
C.HRA Owner Occupied Rehabilitation Loan Program Guideline changes.
D.Election of Officers. Chair, Vice-chair, Secretary.
5.ADJOURNMENT
Page 2
SUN MON TUE WED THU FRI SAT
1 2 3 4 5 6
7 8 9 10 11
12 13
14 15 16
5:00 PM SPECIAL COUNCIL MEETING
Interview Ward 1 Council candidates Parkers Lake Room
17 18 19 20
21 22 23 24 25 26 27
28 29 30
April 2019
3400 Plymouth Boulevard Plymouth, MN 55447 OFFICIAL CITY CALENDAR Phone: 763-509-5000 Fax: 763-509-5060
4:30 PM to 7:00 PM Hennepin County Open Book Meeting Lunch Room
7:00 PM PLANNING COMMISSION MEETING
Council Chambers
SUN TUES MON WED THUR FRI SAT
CHANGES ARE
5:00 PM SPECIAL COUNCIL MEETING Discuss design of Plymouth Creek Center with Architect Medicine Lake Room
7:00 PM REGULAR COUNCIL MEETING Council Chambers
5:00 PM SPECIAL COUNCIL MEETING Interview Architects for Plymouth Creek Center renovation Medicine Lake Room 7:00 PM REGULAR COUNCIL MEETING Council Chambers
7:00 PM HOUSING AND
REDEVELOPMENT
AUTHORITY
MEETING
Parkers Lake Room
5:30 PM SPECIAL COUNCIL MEETING Review Ward 1 Council applicants & vacancies on PRAC, Bassett and Elm Creek Water-shed Management Commissions Parkers Lake Room
7:00 PM PLANNING COMMISSION MEETING Council Chambers
5:30 PM SPECIAL COUNCIL MEETING
Economic Development Discussion (Part 1) Medicine Lake Room
9:00 AM-11:00 AM City Sampler
Maintenance Facility 14900 23rd Ave. N.
Page 3
SUN MON TUE WED THU FRI SAT
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
May 2019
3400 Plymouth Boulevard Plymouth, MN 55447 OFFICIAL CITY CALENDAR Phone: 763-509-5000 Fax: 763-509-5060
7:00 PM PLANNING COMMISSION MEETING Council Chambers
7:00 PM ENVIRONMENTAL QUALITY COMMITTEE MEETING Medicine Lake Room
7:00 PM PARK & REC ADVISORY COMMISSION MEETING Council Chambers
7:00 PM PLANNING COMMISSION MEETING Council Chambers
7:00 PM HOUSING AND
REDEVELOPMENT
AUTHORITY
MEETING
Parkers Lake Room
SUN TUES MON WED THUR FRI SAT
MEMORIAL DAY
CITY OFFICES CLOSED
5:30 PM SPECIAL COUNCIL MEETING Economic Development Discussion (Part 2) Medicine Lake Room
5:30 PM SPECIAL COUNCIL MEETING
Discuss BRT option for Highway 55 Medicine Lake Room
7:00 PM REGULAR COUCIL MEETING
Council Chambers
5:30 PM SPECIAL COUNCIL MEETING Fire Station Space Needs Assessment & Design Recommendations Medicine Lake Room 7:00 PM REGULAR COUNCIL MEETING Council Chambers
Page 4
SUN MON TUE WED THU FRI SAT
1
2
3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19
7:00 PM PLANNING COMMISSION MEETING
Council Chambers
20 21 22
23 24 25
26 27
28 29
June 2019
3400 Plymouth Boulevard Plymouth, MN 55447
OFFICIAL CITY CALENDAR Phone: 763-509-5000 Fax: 763-509-5060
5:00 PM SPECIAL COUNCIL MEETING
Preliminary Budget Discussion Medicine Lake Room 7:00 PM REGULAR COUNCIL MEETING
Council Chambers
7:00 PM ENVIRONMENTAL QUALITY COMMITTEE MEETING
Medicine Lake Room
7:00 PM PARK & REC ADVISORY COMMISSION MEETING
Plymouth Creek Center
7:00 PM PLANNING COMMISSION MEETING Council Chambers
SUN TUES MON WED THUR FRI SAT
CHANGES ARE NOTED IN RED
5:30 PM SPECIAL COUNCIL MEETING Snow/Ice Removal Policy Medicine Lake Room 7:00 PM REGULAR COUNCIL MEETING Council Chambers
7:00 PM HOUSING AND
REDEVELOPMENT
AUTHORITY
MEETING
Parkers Lake Room 30
Page 5
Note: Special Meeting topics have been set by Council; all other topics are tentative.
EDA refers to the Economic Development Authority
Tentative Schedule for
City Council Agenda Items
April 30, Special, 5:30 p.m. Medicine Lake Room
•Economic development discussion (Part 1)
May 14, Special, 5:30 p.m. Medicine Lake Room
•Discuss BRT option for Highway 55
May 14, Regular, 7:00 p.m. Council Chambers
•Public improvement and assessment hearing for the Candlelight Terrace Street reconstruction
project (ST199001)
May 21, Special, 5:30 p.m. Medicine Lake Room
•Economic development discussion (Part 2)
May 28, Special, 5:30 p.m. Medicine Lake Room
•Fire Station space needs assessment and design recommendations
May 28, Regular, 7:00 p.m. Council Chambers
•Update from the League of Minnesota Cities and Insurance Trust
June 11, Special, 5:00 p.m. Medicine Lake Room
•Preliminary Budget Discussion
June 11, Regular, 7:00 p.m. Council Chambers
•Accept musical instrument donation from the Plymouth Rotary Club for the Zachary
Playground renovation
June 25, Special, 5:30 p.m. Medicine Lake Room
•Snow/ice removal policy
June 25, Regular, 7:00 p.m. Council Chambers
(CANCELLED)July 9, Regular, 7:00 p.m. Council Chambers
July 23, Regular, 7:00 p.m. Council Chambers
August 13, Regular, 7:00 p.m. Council Chambers
August 20, Special, 5:30 p.m., Medicine Lake Room
•Budget/CIP
August 27, Special, 5:30 p.m., Medicine Lake Room
•Budget/CIP
August 27, Regular, 7:00 p.m. Council Chambers
Page 6
September 3, Special, 5:30 p.m., Medicine Lake Room
•Budget/CIP (if needed)
September 10, Regular, 7:00 p.m. Council Chambers
September 24, Regular, 7:00 p.m. Council Chambers
October 8, Regular, 7:00 p.m. Council Chambers
October 22, Regular, 7:00 p.m. Council Chambers
November 12, Special, 5:30 p.m., Medicine Lake Room
•Budget/CIP (if needed)
November 12, Regular, 7:00 p.m. Council Chambers
November 26, Regular, 7:00 p.m. Council Chambers
December 10, Regular, 7:00 p.m. Council Chambers
Page 7
BUDGET PROCESS
Budget Calendar
2020-2021 Biennial Budget Preparation & 10-yr Capital Improvement Plan
Date Category Description
April 22, 2019
Budget
Departments receive budget instruction
April – June 2019 Budget Departments prepare budgets
May 13, 2019 Budget Personnel changes submitted to HR
June 10, 2019 Budget Budgets submitted to Finance
June 11, 2019 Budget Council Study Session – Budget Goals
July 8 – July 17, 2019 Budget Department meetings
August 9, 2019 Budget Council receives budget materials for upcoming meeting
August 20, 2019 Budget & CIP Council study session (Budget & CIP meeting #1)
August 27, 2019 Budget & CIP Council Study Session (Budget & CIP meeting #2)
Council Regular Session (Financial Overview & Utility Study)
September 3, 2019 Budget & CIP Council Study Session (Budget meeting #3) (if needed)
September 10, 2019 Budget Council adopts preliminary levies & budget (Budget meeting #4)
October 2, 2019 CIP Planning Commission public hearing
November 12, 2019 Budget Council Study Session (Budget meeting #5) (If needed)
December 10, 2019 Budget & CIP Budget Public Hearing, CIP, Budget & Levy Adoption
December 27, 2019 Budget Levy is certified with Hennepin County
Page 8
City of Plymouth
News Release
For Immediate Release
April 15, 2019
Contact: Sara Lynn Cwayna
Public Safety Education Specialist
City of Plymouth
763-509-5198
scwayna@plymouthmn.gov
Home Alone Workshops for children slated for May
Plymouth, Minn. – Two Home Alone Workshops are set for 6:30-7:45 p.m. Tuesday, May 14 and
Wednesday, May 15 in the second-floor training room of the Plymouth Public Safety Building, 3400
Plymouth Blvd.
This Plymouth Public Safety Department program is geared toward children ages 8-10.
The workshop teaches children how to respond to an emergency if they’re home alone. Public safety
staff work interactively with participants to discuss a variety of scenarios and issues, including dialing
911, fire prevention in the home, personal safety, severe weather awareness, scalds and burns, home
fire escape plans, internet safety and cyber bullying.
Cost is $5 for each child. Class size is limited to 30 participants and early registration is encouraged.
To register, call the Parks and Recreation Department at 763-509-5200 or visit
plymouthmn.gov/recreation.
-30-
Page 9
Page 10
Pharmaceutical Online News | March 25, 2019
Pelican BioThermal Announces Asia
Award For Excellence
Company celebrates major win at Asia-Pacific Bioprocessing Excellence Awards
Pelican BioThermal, the global name in temperature controlled packaging, was announced as a
winner at an annual awards ceremony which recognizes the excellence of suppliers serving the
biologics industry.
Pelican BioThermal is celebrating its prestigious achievement in the Passive Packaging award
category of the Asia-Pacific Bioprocessing Excellence Awards as the company continues to expand its
presence in Asia.
As Pelican BioThermal continues to increase its infrastructure and operations in Asia, its key role as
a supplier of high performing passive packaging to the biologics industry in the region was rewarded
with this coveted award.
Following nomination for the Passive Packaging category award, which was presented at the
Biologistics World Asia 2019 conference in Singapore, Pelican BioThermal was announced as
triumphant winners. The company was presented with the award following an in-depth judging
process whereby more than 30,000 professionals from the biologics industry were invited to vote for
Pelican BioThermal and fellow finalists.
Page 11
Benson Teo, Pelican BioThermal’s Senior Director of Sales, Asia, said: “We are excited and humbled
to receive this award from the industry in recognition of the high performing products and services
we provide.”
“Congratulations to the team at Pelican BioThermal on this latest award. We would especially like to
thank all the customers who placed their trust in us to meet their requirements and deliver the
expected results. We will continue to innovate while providing the best pioneering products possible
for our customers in Asia and worldwide.”
Pelican BioThermal is a global leader in providing the life sciences industry with the most
comprehensive suite of patented and award-winning thermal protection packaging solutions for the
safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood supplies.
This latest award follows Pelican BioThermal’s Supply Chain Innovator accolade awarded to its team
in the US in 2018. Also, in 2018its European office, Peli BioThermal, received its second successive
Queen’s Award for Enterprise for International Trade, the United Kingdom’s most distinguished
business award.
To learn more about the portfolio of passive temperature controlled packaging including Crēdo™
Cube, Chronos™ Express and Advance, CoolPall™ Vertos and Flex and Crēdo™ on Demand rental
program, visitwww.pelicanbiothermal.com
Pelican BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman
Capital, a private equity investment firm based in New York and San Francisco.
About Pelican Products
Pelican Products, Inc. is the global leader in the design and manufacture of high-performance
protective cases, temperature-controlled packaging solutions, advanced portable lighting systems
and rugged gear for professionals and outdoor enthusiasts. Their products are used by professionals
in the most demanding markets including fire safety, law enforcement, defense/military, aerospace,
entertainment, industrial and consumer. Pelican™ products are designed and built to last a lifetime.
The company operates in 21 countries, with 22 international sales offices and six manufacturing
facilities around the globe. In Europe, the company does business under the name Peli Products,
S.LU. For more information, visit pelican.com or behrmancap.com
About Pelican BioThermal
Pelican BioThermal LLC offers the widest range of temperature controlled packaging and service
solutions to the global life sciences industry. The company’s products ensure that delicate biological
materials arrive intact and effective, despite exterior environments. Pelican BioThermal is dedicated
to developing innovative products designed to fulfill the complex needs of the global life sciences
industry. The company’s efforts have received recognition including the U.S. Army’s Greatest
Inventions and the Made in Minnesota Manufacturing award for supply chain innovators. Pelican
BioThermal’s customers benefit from its extensive expertise in ensuring that temperature stability is
maintained throughout the distribution chain. The company also offers a complete portfolio of
services and software to support end-to-end temperature-controlled packaging asset management.
In Europe, the company does business under the name Peli BioThermal Limited. For more
information, visit pelicanbiothermal.com.
SOURCE: Pelican BioThermal
Page 12
1/3
BUSINESS
Sterilization plant closure in Illinois is a
challenge for Minnesota medical device
makers
Many have been forced to find other locations to sterilize their
products.
By Joe Carlson (http://www.startribune.com/joe-carlson/271816721/) Star Tribune
APRIL 13, 2019 — 10:32AM
Medical device companies across the state are scrambling to prevent product shortages
after the abrupt closure of a major plant in Illinois that sterilizes finished medical
products.
The Illinois Environmental Protection Agency on Feb. 15 ordered the Sterigenics plant in
Willowbrook, Ill., to seal its containers of ethylene oxide (EtO) and stop using the
chemical to sterilize devices. Although the gas can be used safely to sterilize medical
devices, Illinois regulators said the chemical was being emitted from the factory and
creating cancer risks for thousands of people near the plant.
With the plant now idle for two months, litigation is ongoing between Sterigenics and
Illinois officials in federal and state court over what happens next.
Meanwhile, device makers with big Twin Cities operations like Medtronic, Boston
Scientific, Smiths Medical and Teleflex are faced with the prospect of managing
customer demand with existing stock or getting regulatory permission to move
sterilization functions to another plant.
Medtronic PLC, run from offices in Fridley, said the decision to close the Willowbrook
plant is creating “supply challenges” in its surgical-innovations business, which includes
minimally invasive surgical stapling devices, vessel-sealing and wound-closure devices,
electrosurgery products, hernia mechanical devices, mesh implants and gynecology
products.
“Sterilization is a vital requirement for medical technology, and Sterigenics plays an
important role as a source of sterilization to Medtronic and others in this industry,”
spokesman Fernando Vivanco said in an e-mail.
All eight members of Minnesota’s U.S. House delegation have signed a letter to the FDA
urging the agency to act quickly to prevent shortages of medical devices. The letter noted
that it normally takes up to six months to get regulatory approval to change a
sterilization source for a medical device production system, but many manufacturers
affected have only one or two months’ worth of inventory on hand to meet customer
demand.
The lawmakers said the environmental concerns in Willowbrook are “very alarming and
should continue to be addressed,” but also note in the letter
(https://www.documentcloud.org/documents/5816438-Sterigenics-Eo-Mn-Cong-Ltr-to-
Fda-3-5-19-002.html) that the sudden closing of the plant ”is posing significant challenges
to the supply of lifesaving medical devices.”
All surgical instruments must be sterilized before touching a patient, to prevent
microbes left on the device after manufacturing from infecting patients. But many
devices are made of soft plastics and other materials that can’t be treated with heat or
radiation, which is why the FDA allows companies to use EtO sterilization instead.
EtO is a colorless gas that has long been produced in industrial quantities for a variety of
industries, including for materials manufacturing, agricultural fumigation and
sterilization of medical products too delicate to be cleaned through other means, like
heat or radiation.
MARK BLACK – CHICAGO TRIBUNE FILE
Protesters rallied outside Sterigenics’ Oak
Brook, Ill., headquarters in 2018. In February,
the Illinois EPA ordered the firm to stop using
Page 13
2/3
“Unfortunately,” the U.S. Labor Department sa
(https://www.osha.gov/SLTC/ethyleneoxide/index.html) id, “EtO possesses several
physical and health hazards that merit special attention.” Chronic exposure, the
department said, “has been associated with the occurrence of cancer, reproductive
effects, mutagenic changes, neurotoxicity, and sensitization.”
Sterigenics said that on a typical day, the Willowbrook plant sterilized 200 pallets of
medical products, including 1,000 cardiac devices, 1,500 surgical-procedure kits, 16,000
catheters, and thousands of diabetes monitoring and care kits, renal care products,
neurological devices and respiratory-care products. A letter from the FDA’s medical
device branch (https://www.documentcloud.org/documents/5816437-CDRH-Message-
on-EtO-Plants-March-7-2019-PDF.html) said that 90% of the work at the plant is related
to medical devices, and the closure affects more than 100 manufacturers of devices.
Minnesota health technology trade group the Medical Alley Association said the effect is
especially acute for small and midsize companies, for which the Willowbrook plant was
the only qualified and validated sterilization source that could handle their smaller
product volumes. Medical Alley CEO Shaye Mandle urged the FDA to consider special
measures like expediting new requests for sterilization source approvals.
In the wake of the Willowbrook closure, the FDA said it is working with device
companies to help them move to another plant or find another acceptable sterilization
method.
“Supply issues can lead to shortages of medical devices — and can pose a threat to public
health by delaying or disrupting critical care for patients. Mitigating product supply
issues and working to prevent patient harm from device shortages are important to the
FDA,” the FDA’s web page on the EtO sterilization s
(https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/GeneralHospitalDevicesandSupplies/ucm634204.htm#news)
tates.
Teleflex Medical, which in 2017 acquired Minnesota’s Vascular Solutions, said some of
its customers may have to go without certain devices, if suitable substitutes can’t be
found and the company can’t get a new sterilization process approved by the FDA in
time.
Teleflex sells a wide range of products for vascular and interventional procedures, as
well as for cardiac and surgical care, anesthesia, respiratory care, urology and emergency
medicine. The company sterilizes about 7 million units of products at Willowbrook
annually.
“The unplanned shutdown of the Willowbrook facility will affect Teleflex’s ability to
supply hospitals and health care providers with the products described above,” Teleflex
global procurement director Gregg Twomey said in a declaration filed as an exhibit to a
lawsuit filed by Sterigenics against Illinois environmental officials.
Smiths Medical, which has its operations headquarters in Plymouth, has alerted
customers to a disruption affecting many of its Bivona tracheostomy tubes, which are
used to create airways in the neck. Smiths Medical declined to comment for this story.
Major Minnesota employer Boston Scientific Corp.’s urology and pelvic-health products
division sterilizes devices at the Willowbrook plant. The company advised in a Feb. 19
securities filing
(https://www.sec.gov/Archives/edgar/data/885725/000088572519000011/a2018form10-
k.htm) that it planned to rely on existing stock while accelerating plans to move to
existing sterilization facilities that are already in the company’s supply chain.
In an updated statement, the company said the FDA as of March 28 has granted
approval for the company to sterilize its men’s health products at a different location.
Joe Carlson writes about medical technology in Minnesota for the Star Tribune.
joe.carlson@startribune.com 612-673-4779 _JoeCarlson
Page 14
Startup raises $6M to turn
silkworm cocoons into eyedrops
SilkTech Biopharmaceuticals makes eye drops from silk cocoons
SILK TECHNOLOGIES
By: Maddy Kennedy – Minne Inno Apr 16, 2019, 2:38pm EDT
Editor's note: This story comes from our online sister publication, Minne Inno, which focuses on the
Twin Cities startup scene. Want more stories about tech and innovation in the Minneapolis-St. Paul
area? Subscribe to the Beat by Minne Inno, a free daily email newsletter that breaks down everything
you need to know about what's new in business the Twin Cities.
A biotech startup that aims to turn silkworm cocoons into a treatment for dry-eye
disease has raised $6.2 million in venture capital funding.
Plymouth-based SilkTech Biopharmaceuticals announced Tuesday that will put the
capital toward an upcoming 300-patient clinical trial of its product, an eye drop made
from silk fibers.
Skyview Capital, a Los Angeles-based investment firm, was the sole investor in the
round. Skyview also provided capital for SilkTech’s previous venture capital raise.
Page 15
In late 2017, SilkTech landed $11.2 million. Leading up to that round of funding, SilkTech
was backed by angel investors and federal funding.
SilkTech Founder and CEO Brian Lawrence is a biomedical engineer whose research has
centered around how silk can treat eye conditions. Lawrence previously told the Business
Journal that the company initially planned to develop a silk-based medical device to treat
eye wounds, but abandoned the effort when the market didn’t prove large enough. The
company revamped its strategy to focus on eyedrops and the dry-eye disease market,
which Lawrence estimates is worth about $4 billion.
Tears help to maintain eye health, according to the American Optometric Association.
Dry eye is a common and often chronic problem, particularly in older adults. Those affected
typically do not produce enough tears or their tears are of poor quality. SilkTech
estimates that nearly 16 million patients in the U.S. have been diagnosed with dry eye,
and approximately 30 to 40 million more individuals struggle with it but remain
undiagnosed.
“As a patient who himself suffers from dry eye, I could not be more enthusiastic about
seeing this novel therapeutic entering the clinic,” said Skyview CEO Alex Soltani in a
release. “As an investment partner, we believe this technology could represent a
paradigm shift in the treatment of this disease.”
Although silk is best known for its use in fabrics, scientists have started researching
whether it can serve as a foundation for new medicines. Several groups have already
found success with the technology. Massachusetts-based Cocoon Biotech is developing
arthritis treatments based on silk proteins. And Tufts University uses silk to store blood
samples at room temperature.
Page 16